Geron Co. (NASDAQ:GERN – Free Report) – Stock analysts at HC Wainwright issued their FY2029 EPS estimates for Geron in a report released on Wednesday, February 26th. HC Wainwright analyst E.

Market forces rained on the parade of Geron Corporation (NASDAQ:GERN) shareholders today, when the analysts downgraded their forecasts for this year. Both revenue and earnings per share (EPS ...

Scotiabank lowered the firm’s price target on Geron (GERN) to $4 from $6 and keeps an Outperform rating on the shares. While the company’s Q4 results were in-line with expectations ...

John Scarlett; Chairman of the Board, President, Chief Executive Officer; Geron Corp Jim Ziegler; Executive Vice President, Chief Commercial Officer; Geron Corp Joseph Eid; Executive Vice ...

John Scarlett; Chairman of the Board, President, Chief Executive Officer; Geron Corp Jim Ziegler; Executive Vice President, Chief Commercial Officer; Geron Corp Joseph Eid; Executive Vice President- ...

Investing.com -- Shares of Geron Corp (NASDAQ: NASDAQ:GERN) plummeted 30% following the company’s release of fourth-quarter earnings that failed to meet analyst expectations and its guidance that left ...

Geron shares fell 30% to $1.66 after the company reported a fourth-quarter loss that was wider than expected. The biopharmaceutical company had a quarterly loss of $25.4 million, or 4 cents a ...

On Wednesday, H.C. Wainwright adjusted its stance on Geron Corporation (NASDAQ:GERN), shifting from a Buy to a Neutral rating. The research firm's decision comes in the wake of Geron's recent ...

(RTTNews) - Geron Corporation (GERN) released Loss for fourth quarter that decreased from the same period last year and beat the Street estimates. The company's bottom line totaled -$25.35 million ...